The Forum
The 2021 Virtual World Medical Innovation Forum will focus on the growing impact of gene and cell therapy.
Virtual | May 19–21, 2021
Gene and cell therapy holds immense potential to advance the quality of patient care, reduce cost, and improve outcomes. Systemic complexity, however, can hinder the translation of breakthroughs to clinical care.
Our collective mission: finding solutions to the ethical, medical, operational, and economic challenges confronting GCT-driven care to ensure that patients, providers, and healthcare organizations benefit as soon as possible.
Who Attends
Pharma
Provider
Venture Captial
Medical Device
Investors
Industry Leaders
Engage with peers from across the GCT and machine learning ecosystem. Meet other executives, decision-makers, and business leaders from health care, pharma, medical devices, and biotech.
Clinicians and Investigators
The one event where physician and clinician leaders connect with peers across the medical landscape. Attend plenary panels, networking events, and fireside chats to capture insight into how GCT and other data-driven technology is enhancing the care continuum.
Healthcare IT
Identify emerging needs for analytics, storage, data, and other services critical to the success of GCT in health care. Connect with partners and innovators; develop long-term strategy.
Academics
Connect with other PhDs, researchers, engineers, and practitioners developing, testing, and optimizing new applications of GCT and machine learning in health care. Identify clinical, financial, and commercial partners.
Data Scientists
GCT-enabled medicine won’t happen without teams of gifted data scientists. Connect with investigators, industry leaders, IT providers, and others to discuss data challenges and solutions.
Attendees by Industry
0%
0%
Non-Profit and Government
0%
Health Information Technology
0%
0%
0%
0%
2020 COVID-19 White Paper
The long-term impacts of COVID-19 on healthcare, society and the economy are only beginning to reveal themselves. More than a thousand experts provide their thoughts on what’s ahead.
We’re pleased to share the following analysis.
The Difference
Why You Need to Be a Part
Past Forums
The Forum has hosted many top-tier speakers since its inception. See the past keynoters, as well as access to videos of the panels.
Steering Committee
Nino Chiocca, MD, PhD, Neurosurgeon-in-Chief and Chairman, Neurosurgery, BH; Harvey W. Cushing Professor of Neurosurgery, HMS (2021 Co-Chair)
Susan Slaugenhaupt, PhD, Scientific Director, Mass General Research Institute, MGH; Professor, Neurology, HMS (2021 Co-Chair)
Ravi Thadhani, MD, CAO, Mass General Brigham; Professor of Medicine and Faculty Dean for Academic Programs, HMS (2021 Co-Chair)
Luk Vandenberghe, PhD, Grousbeck Family Chair in Gene Therapy, MEE; Associate Professor, Ophthalmology, HMS (2021 Co-Chair)
Xandra Breakefield, PhD, Geneticist, MGH; Professor, Neurology, HMS
Bob Carter, MD, PhD, Chairman, Department of Neurosurgery, MGH; William and Elizabeth Sweet, Professor of Neurosurgery, HMS
Florian Eichler, MD, Director, Center for Rare Neurological Diseases, MGH; Associate Professor, Neurology, HMS
Jean-Francois Formela, MD, Partner, Atlas Venture
Meredith Fisher, PhD, Partner, Mass General Brigham Ventures
Pat Fortune, PhD, VP, Market Sectors, Mass General Brigham Innovation
Anna Greka, MD, PhD, Associate Professor, Medicine, BH; Associate Professor, Medicine, HMS
Reid Huber, PhD, Partner, Third Rock Ventures
Ole Isacson, MD, PhD, Director, Neuroregeneration Research Institute, McLean; Professor, Neurology and Neuroscience, HMS
J. Keith Joung, MD, PhD, Robert B. Colvin, M.D. Endowed Chair in Pathology & Pathologist, MGH; Professor of Pathology, HMS
Adam Koppel, MD, PhD, Managing Director, Bain Capital Life Sciences
Jeannie Lee, MD, PhD, Molecular Biologist, MGH; Professor of Genetics, HMS
John Lepore, MD, SVP, Head of Research, GlaxoSmithKline
Marcela Maus, MD, PhD, Director, Cellular Immunotherapy, Cancer Center, MGH; Assistant Professor, HMS
Marie McDonnell, MD, Chief, Diabetes Section and Director, Diabetes Program, BH; Lecturer, HMS
Patricia Musolino, MD, PhD, Co-Director Pediatric Cerebrovascular Service, MGH; Assistant of Neurology, HMS
Chandra Ramanathan, PhD, Global Head, Pharma R&D Open Innovation, Bayer
Alfred Sandrock, MD, PhD, EVP, R&D and CMO, Biogen
Bastiano Sanna, PhD, EVP, Chief of Cell & Gene Therapies and VCGT Site Head, Vertex Pharmaceuticals
Christine Seidman, MD, Director, Cardiovascular Genetics Center, BH; Thomas W. Smith Professor of Medicine and Genetics, HMS
